UK approves antibody COVID treatment

The United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) announced on Friday that it has approved the use of the monoclonal antibody treatment for COVID-19 developed by Regeneron Pharmaceuticals and F. Hoffmann-La Roche AG.

According to the regulator, the drug will be used for either prevention or treatment of coronavirus. Moreover, it can be administered either through injection or infusion, and the watchdog stated that it also reduces the likelihood of being admitted to the hospital due to COVID.

UK Health and Social Care Secretary Sajid Javid commented on the news: “This treatment will be a significant addition to our armory to tackle COVID-19 – in addition to our world-renowned vaccination program and life-saving therapeutics dexamethasone and tocilizumab.”



Breaking the News / OL



Source link

About the author: admin Academy

admin

Alcuni articoli sono qui aggregati per darti un'informazione continua e costante, pertanto, sotto ognuno di essi troverai la fonte: entra nel sito di riferimento per avere ulteriori news ed informazioni sull'economia mondiale, ti sarà utile. Ti aspetto nell'Academy!

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento